====== Deshayne Fell ======

{{ ::dfell-web-1-002-290x290.jpeg?200|}}

Dr. **Deshayne Fell** is a Canadian perinatal epidemiologist based in Ottawa, Ontario.

===== Career and Affiliations =====

==== CHEO Research Institute ====

Fell is a scientist at the [[CHEO Research Institute]].((//Deshayne Fell.// CHEO Research Institute. Retrieved April 21, 2022, from https://archive.ph/J54qa))

==== University of Ottawa ====

Fell is an Associate Professor in the School of Epidemiology and Public Health at the [[University of Ottawa]].

==== ICES ====

Fell is an Adjunct Scientist at the [[Institute for Clinical Evaluative Sciences]] (ICES).

==== World Health Organization ====

Fell has been a member of two [[WHO Technical Advisory Groups]] related to maternal immunization.((//Methodological Challenges of Studying Perinatal Outcomes Following Immunization During Pregnancy: A Case Study on Influenza.// (2019). McGill University. https://web.archive.org/web/20220422010132/https://www.mcgill.ca/epi-biostat-occh/files/epi-biostat-occh/dfell-announcement-25mar19.pdf))

==== Society for Epidemic Research ====

Fell is a faculty member of the [[Society for Epidemic Research]].((//Deshayne Fell.// Society for Epidemiologic Research. Retrieved April 21, 2022, from https://web.archive.org/web/20220422011148/https://epiresearch.org/annual-meeting/2022-meeting/ser-faculty/deshayne-fell/))

==== World Vaccine Congress ====

Fell presented at the [[World Vaccine Congress]] in April 2022 on the subject of maternal immunity and vaccines.((//Agenda | Vaccine Congress USA.// (2022, April 21). World Vaccine Congress Washington 2022. https://archive.ph/Iea3Q)) The WVC is sponsored by [[pharmaceutical_companies:Baxter]], [[medical_technology_companies:BD]], [[pharmaceutical_companies:CanSinoBio]], [[pharmaceutical_companies:Codex DNA]], [[pharmaceutical_companies:Dynavax]], [[pharmaceutical_companies:Emergent BioSolutions]], [[medical_technology_companies:Eurofins]], [[pharmaceutical_companies:Immunomic Therapeutics]], [[pharmaceutical_companies:Intravacc]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Medicago]], [[pharmaceutical_companies:MilliporeSigma]] (a [[pharmaceutical_companies:Merck]] company), [[pharmaceutical_companies:Novavax]], [[pharmaceutical_companies:Sabin Vaccine Institute]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Sino Biological]], and [[pharmaceutical_companies:VBI Vaccines]], among many others.((//sponsors & exhibitors | Vaccine Congress USA.// (2022, April 21). World Vaccine Congress Washington 2022. https://archive.ph/1iOkG))

==== Public Health Agency of Canada ====

Fell is a liaison representative for the [[Canadian Association for Immunization Research, Evaluation and Education]] (CAIRE) on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
===== Research =====

Fell's research uses large, linked population databases and registries to improve our understanding of factors affecting maternal and infant population health. Her specific focus includes infection and immunization during pregnancy and their relationship with birth outcomes and longer-term pediatric health outcomes, including safety and effectiveness of maternal immunization.

==== Funding ====

Fell has conducted research with funding from the [[Bill & Melinda Gates Foundation]],((Ganton, J. (2018, January 19). //Newborn sepsis: Could routinely collected blood spots help with early detection?// Ontario Hospital Research Institute. https://web.archive.org/web/20220422014854/http://www.ohri.ca/newsroom/story/view/799?l=en)) ((//Ottawa Hospital Research Institute.// (2015, November). Bill & Melinda Gates Foundation. https://archive.ph/tHJ9f)) including as a [[Principal Investigator]]. At least one of these studies was also funded and/or coordinated by [[PATH]] and the [[WHO Initiative for Vaccine Research]], funded by the [[Centers for Disease Control and Prevention]] (CDC).((Fell, D. B., Johnson, J., Mor, Z., Katz, M. A., Skidmore, B., Neuzil, K. M., Ortiz, J. R., & Bhat, N. (2017). //Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review.// BMJ open, 7(9), e016526. https://doi.org/10.1136/bmjopen-2017-016526))